All lobbying filings

EAST END GROUP, LLC

EAST END GROUP, LLC filed a Q1 report for ALVOGEN on April 14, 2026, reporting $45,000 in lobbying income.

Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products

All filings by EAST END GROUP, LLC · Everything ALVOGEN has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 14, 2026

Income

$45,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 1

KELLY CHILDRESS LANGE

Previously held: Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals. Issues related to domestic manufacturing and on-shoring pharmaceuticals.

Tariff (miscellaneous tariff bills)

Section 232 investigation into pharmaceuticals and unfair trade practices.

Manufacturing

Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.